PEDRA(TM) Technology Receives FDA Breakthrough Device Designation for its PEDRA(TM) Xauron(TM) Real-Time Tissue Perfusion System

Novel perfusion monitor achieves FDA Breakthrough Device Designation for real-time, periprocedural monitoring of tissue perfusion in patients with critical limb threatening ischemia SINGAPORE, Jan 25, 2021 -- (Healthcare Sales & Marketing Network) -- P... Devices, Monitoring, FDA PEDRA Technology, tissue perfusion, Xauron, critical limb ischemia
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news